[ad_1]
BOSTON and SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) — PathAI, a world chief in synthetic intelligence (AI)-powered know-how for pathology, and Datavant, the chief in serving to organizations securely join well being knowledge, introduced a collaboration to allow compliant connectivity of PathAI’s pathology platform to life sciences trial knowledge and different real-world knowledge.
PathAI’s digital platform contains 5 million specimens collected from historic biopsies and resections. PathAI applies AI and machine studying to guage molecular traits of cells for improved diagnostic precision in areas like oncology and NASH, in addition to enhance measurement of therapeutic effectiveness. PathAI will leverage Datavant’s compliant connectivity know-how to reinforce their pathology insights with real-world knowledge like digital well being information, claims, and different sources to allow granular well being outcomes analyses. The partnership will even allow life sciences organizations to attach their inner trial knowledge to the platform to extend precision in characterizing a affected person’s illness and the depth of proof on sufferers’ response to remedy.
“We’re excited to hitch the Datavant ecosystem,” mentioned Andrew H. Beck, CEO of PathAI. “The perception we will carry to researchers will increase exponentially once we can compliantly join extremely granular pathology knowledge to different wealthy real-world knowledge that describes affected person well being standing.”
“Firms like PathAI are making a beforehand inaccessible supply of information obtainable to life sciences organizations to speed up drug discovery,” mentioned Travis Could, President and Founding father of Datavant. “Till lately, pathology knowledge was a bodily slide of tissue accompanied by an unstructured textual content report. Now it’s a digital piece of information that may be analyzed, and related to different real-world knowledge to yield unprecedented perception about illness and potential therapies.”
About PathAI
PathAI is a number one supplier of AI-powered analysis instruments and companies for pathology. PathAI’s platform guarantees substantial enhancements to the accuracy of analysis and the efficacy of remedy of ailments like most cancers, leveraging trendy approaches in machine and deep studying. Primarily based in Boston, PathAI works with main life sciences firms and researchers to advance precision drugs. To be taught extra, go to pathai.com.
About Datavant
Datavant’s mission is to attach the world’s well being knowledge to enhance affected person outcomes. Datavant works to cut back the friction of information sharing throughout the healthcare trade by constructing know-how that protects the privateness of sufferers whereas supporting the linkage of affected person well being information throughout datasets. Study extra about Datavant at www.datavant.com.
Media Contacts:
Caty Reid
Senior Director, Company Advertising, PathAI
caty.reid@pathai.com
Elenee Argentinis
Head of Advertising, Datavant
elenee@datavant.com
[ad_2]
